Drug data last refreshed 5h ago · AI intelligence enriched 5d ago
Children's Motrin Cold is a fixed-dose combination oral suspension containing ibuprofen (a nonsteroidal anti-inflammatory) and pseudoephedrine hydrochloride (a nasal decongestant). It is indicated for symptomatic relief of cold and flu symptoms in pediatric patients. The combination targets both fever/pain and nasal congestion through dual mechanisms of action.
As a mature OTC-adjacent pediatric cold remedy approaching loss of exclusivity, the brand team is likely focused on defensive strategies and operational efficiency rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Children's Motrin Cold offers limited growth opportunity but strong operational and defensive strategy experience in a mature, highly competitive market. Career progression typically involves cost-management expertise, portfolio rationalization, and transition planning as the product approaches or enters post-LOE phase.
Worked on CHILDREN'S MOTRIN COLD at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.